Medi Pharma Vision, Ltd.
Dr. Petr Rysavka is leading person of Medi Pharma Vision Company, Brno. He was graduated Ph.D. in 2019 at the Faculty of Chemistry BUT in Brno, Czech republic. Previously, his research activites were focused on development of new probiotic preparatives based on biofilm on combined carrier with prebiotic component. Currently, the research and therapeutical activites are oriented mainly to the development and application of personalized probiotics with the unique composition based on analysis of individual gut microbiota and personal data.
THE EUROBIOTECH JOURNAL (Active Now!)The EuroBiotech Journal is the official journal of European Biotechnology Thematic Network Association (EBTNA), an international journal for scientists who work in the field of biotechnology.